This October, the annual Hong Kong Wine & Dine Festival returns to the Central Harbourfront Event Space for a four-day celebration of the city's world-class culinary scene ? and this year, for the ...

(Alliance News) - Genflow Biosciences PLC on Friday reported strong data from a proof-of-concept clinical trial of its proprietary SIRT6-centenarian gene therapy for age-related decline in elderly ...

A behavioral telehealth startup called Marble Health is betting on something refreshingly human: real therapists, not AI, can help solve the nation’s youth mental health crisis. In April 2025, sixteen ...

"These RJVA-002 data further support our Smart GLP-1 gene therapy platform approach and suggest that dual gut hormone expression has the potential to produce powerful metabolic effects," said Harith ...

Advanced Gene Therapy Development Solutions: A Comprehensive Platform for Next-Generation Therapeutic Innovation: The landscape of gene therapy has evolved dramatically over the past decade, ...

Gunze Medical and HistoSonics Enter into Exclusive Distributor Agreement in Japan for Noninvasive Platform and Proprietary Sonic Beam Therapy Using Histotripsy Technology Gunze Limited (Headquarters: ...

OSAKA, Japan, October 08, 2025--(BUSINESS WIRE)--Gunze Limited (Headquarters: Osaka, Japan; President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce that its wholly owned subsidiary, Gunze ...

OSAKA, Japan, October 09, 2025--(BUSINESS WIRE)--Gunze Limited (Headquarters: Osaka, Japan; President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce that its wholly owned subsidiary, Gunze ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Investing.com - H.C. Wainwright initiated coverage on Senti Biosciences, Inc. (NASDAQ:SNTI) with a Buy rating and a price target of $12.00 on Tuesday. The micro-cap biotech company, currently valued ...